This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Theratechnologies Completes Acquisition by Future Pak

Tipranks - Fri Sep 26, 2025

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Theratechnologies ( (TSE:TH) ) has provided an announcement.

Theratechnologies has completed its acquisition by Future Pak, with all common shares acquired for $3.01 per share in cash, plus a contingent value right (CVR) for potential additional payments. This acquisition will lead to the delisting of Theratechnologies’ shares from the Toronto Stock Exchange and Nasdaq, and the company will cease to be a reporting issuer under Canadian securities laws, marking a significant shift in its market presence.

The most recent analyst rating on (TSE:TH) stock is a Hold with a C$4.50 price target. To see the full list of analyst forecasts on Theratechnologies stock, see the TSE:TH Stock Forecast page.

Spark’s Take on TSE:TH Stock

According to Spark, TipRanks’ AI Analyst, TSE:TH is a Neutral.

Theratechnologies’ overall score is driven by positive corporate events, including a favorable acquisition agreement, which boosts shareholder value. Strong technical indicators also support the stock’s outlook. However, financial performance and valuation challenges, such as negative equity and a lack of profitability, weigh on the score.

To see Spark’s full report on TSE:TH stock, click here.

More about Theratechnologies

Theratechnologies is a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care.

Average Trading Volume: 52,391

Technical Sentiment Signal: Hold

Current Market Cap: C$215.6M

Learn more about TH stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.